Coagulation and Fibrinolysis in Preeclampsia and Neonates

Coagulation and fibrinolysis are essential processes in the human body for maintaining normal levels of hemostasis. In preeclampsia, a pregnancy-specific disorder caused by a complex interaction between the mother and her developing fetus, and in neonates, these processes are often disrupted, leading to an imbalanced coagulation-fibrinolysis system and a risk of thromboembolic complications. Understanding of the mechanisms of coagulation and fibrinolysis in these two conditions is important for the identification and management of patients at risk and for the design of more effective treatments. Research in this area is needed to improve the outcomes of pregnant women, neonates, and their offspring.